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Introduction: Severe aortic stenosis (AS) in patients with end-stage liver disease (ESLD) increases the 
morbidity and mortality of orthotopic liver transplantation (OLT). OLT is a surgical intervention with 
serious hemodynamic changes which can contribute to heart failure and cardiac death. Due to in-
creased perioperative mortality, severe AS and ESLD are considered contraindications for OLT or aortic 
valve replacement (AVR)1. Aortic balloon valvuloplasty (BAV) may be a reasonable therapeutic option 
to improve the hemodynamic status and enable OLT2. 
Case report: The patient was a 43-year-old female who had an OLT in 2019 due to fulminant hepatitis 
B. AS was detected in 2018 and it progressed to severe in 2021. In 2021, another decompensation of 
cirrhosis of the liver graft occurred. The patient had Child-Pugh B graft cirrhosis which is according 
to the available data, contraindication for cardiac surgery3. A multidisciplinary meeting was held and 
it was decided to do a BAV as a less invasive procedure before OLT. BAV was made with a satisfactory 
reduction of the transvalvular pressure gradient by 30% and with this procedure, the patient is hemo-
dynamically in a more favorable position for OLT. 
Discussion: BAV was presented as a minimally invasive procedure with fewer complications to sur-
gical replacement for AS in patient with ESLD. In practice, the procedure was proved to have a high 
percentage of complications and only a modest hemodynamic upgrade compared with AVR. There-
fore, valvuloplasty should not be the first choice for AS. However, there are some indications for BAV 
such as a palliative treatment and in patients with AS and ESLD as a bridging procedure to OLT1. This 
procedure enabled our patient to undergo surgery in a hemodynamically more favorable situation. It 
is also necessary to say that a multidisciplinary approach involving gastroenterologists, cardiologists, 
cardiac and abdominal surgeons, and anesthesiologists is the key in the treatment of such patients. 
In conclusion, in patients who are unsuitable for OLT because of AS, BAV, and then OLT may be a good 
approach that permits AVR posttransplantation. However further research is needed to demonstrate 
the advantages and disadvantages of this approach. 
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